Advisors Preferred LLC Has $2.27 Million Position in Procter & Gamble Company (The) $PG

Advisors Preferred LLC grew its position in Procter & Gamble Company (The) (NYSE:PG) by 29.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,746 shares of the company’s stock after purchasing an additional 3,621 shares during the period. Advisors Preferred LLC’s holdings in Procter & Gamble were worth $2,274,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in PG. Gradient Investments LLC increased its holdings in shares of Procter & Gamble by 12.8% in the fourth quarter. Gradient Investments LLC now owns 253,089 shares of the company’s stock valued at $36,270,000 after purchasing an additional 28,777 shares in the last quarter. Cibc World Market Inc. lifted its holdings in Procter & Gamble by 40.6% during the 4th quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock worth $73,351,000 after buying an additional 147,701 shares in the last quarter. World Investment Advisors lifted its holdings in Procter & Gamble by 15.9% during the 4th quarter. World Investment Advisors now owns 105,915 shares of the company’s stock worth $15,179,000 after buying an additional 14,492 shares in the last quarter. Resources Management Corp CT ADV boosted its position in Procter & Gamble by 41.8% in the 4th quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock valued at $11,681,000 after buying an additional 24,010 shares during the last quarter. Finally, Indivisible Partners acquired a new stake in shares of Procter & Gamble in the 4th quarter valued at $2,120,000. Institutional investors own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble declared another quarterly dividend of $1.0885 per share, extending its long record of dividend growth and signaling continued cash-flow strength. P&G Declares Quarterly Dividend, July 2026
• Positive Sentiment: The dividend hike underscores P&G’s status as a defensive income stock, which may appeal to investors looking for stability and reliable returns. Procter & Gamble Just Declared Its 70th Dividend Increase
• Neutral Sentiment: Investor attention has been elevated around PG, but recent search interest does not by itself change fundamentals or earnings outlook. Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
• Neutral Sentiment: Coverage ahead of earnings suggests analysts expect a modest decline in earnings, keeping expectations cautious going into the report. What You Need To Know Ahead of Procter & Gamble’s Earnings Release
• Negative Sentiment: PG is planning about 7,000 job cuts to help offset tariff-related costs, highlighting margin pressure and potential restructuring challenges. Procter & Gamble (PG) Plans 7,000 Job Cuts To Help Offset Tariff Costs

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Jefferies Financial Group upped their price target on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Bank of America lowered their price objective on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Barclays cut their target price on shares of Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. TD Cowen raised their target price on shares of Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a research note on Monday, April 27th. Finally, Rothschild & Co Redburn lowered their price target on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.42.

Procter & Gamble Price Performance

Shares of PG opened at $146.16 on Wednesday. The stock has a market cap of $340.34 billion, a P/E ratio of 21.37, a price-to-earnings-growth ratio of 7.22 and a beta of 0.39. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The stock’s 50-day moving average price is $146.63 and its two-hundred day moving average price is $148.45. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The company had revenue of $21.23 billion during the quarter, compared to analysts’ expectations of $21.52 billion. During the same period in the prior year, the business posted $1.54 EPS. Procter & Gamble’s revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.89 earnings per share for the current year.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.